Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /search-results Disallow: /system-error Disallow: /*api Disallow: */jcr Disallow: /generatepdf Disallow: /content/usergenerated/content/forms/af/ Disallow: /*bin/abbvieforms/refreshlogin Disallow: /DSARegistration Disallow: /favicon.ico Disallow: /content/*/en-us Sitemap: https://www.rinvoqhcp.com/sitemap.xml Sitemap: https://www.rinvoqhcp.com/image-sitemap.xml Sitemap: https://www.rinvoqhcp.com/atopic-dermatitis/sitemap.xml Sitemap: https://www.rinvoqhcp.com/atopic-dermatitis/image-sitemap.xml Sitemap: https://www.rinvoqhcp.com/rheumatoid-arthritis/sitemap.xml Sitemap: https://www.rinvoqhcp.com/rheumatoid-arthritis/image-sitemap.xml Sitemap: https://www.rinvoqhcp.com/psoriatic-arthritis/sitemap.xml Sitemap: https://www.rinvoqhcp.com/psoriatic-arthritis/image-sitemap.xml Sitemap: https://www.rinvoqhcp.com/ulcerative-colitis/sitemap.xml Sitemap: https://www.rinvoqhcp.com/ulcerative-colitis/image-sitemap.xml Sitemap: https://www.rinvoqhcp.com/axspa/sitemap.xml |
Title | RINVOQ® (upadacitinib) | Official Healthcare Professional |
Description | DEFY RINVOQ® (upadacitinib) is approved for treatment of certain patients with RA, PsA, AD, UC, AS and nr-axSpA. See full Prescribing, Use & Safety Info, and BOXED |
Keywords | All Indications |
WebSite | rinvoqhcp.com |
Host IP | 159.180.132.176 |
Location | United States |
Site | Rank |
US$18,483,185
Last updated: 2023-05-03 20:29:37
rinvoqhcp.com has Semrush global rank of 572,645. rinvoqhcp.com has an estimated worth of US$ 18,483,185, based on its estimated Ads revenue. rinvoqhcp.com receives approximately 2,132,676 unique visitors each day. Its web server is located in United States, with IP address 159.180.132.176. According to SiteAdvisor, rinvoqhcp.com is safe to visit. |
Purchase/Sale Value | US$18,483,185 |
Daily Ads Revenue | US$17,062 |
Monthly Ads Revenue | US$511,843 |
Yearly Ads Revenue | US$6,142,105 |
Daily Unique Visitors | 142,179 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
rinvoqhcp.com. | A | 299 | IP: 159.180.132.176 |
rinvoqhcp.com. | NS | 3600 | NS Record: ns-1837.awsdns-37.co.uk. |
rinvoqhcp.com. | NS | 3600 | NS Record: ns-320.awsdns-40.com. |
rinvoqhcp.com. | NS | 3600 | NS Record: ns-620.awsdns-13.net. |
rinvoqhcp.com. | NS | 3600 | NS Record: abvegdmzns1.abbvie.com. |
rinvoqhcp.com. | NS | 3600 | NS Record: abvludmzns1.abbvie.com. |
rinvoqhcp.com. | NS | 3600 | NS Record: abvsgdmzns1.abbvie.com. |
rinvoqhcp.com. | NS | 3600 | NS Record: ns-1450.awsdns-53.org. |
rinvoqhcp.com. | TXT | 3600 | TXT Record: google-site-verification=By6Xt-CgT7P623EQjGX5BTqGRUabyHbQmTwo-9LZTe0 |
Close Please see Important Safety Information, including BOXED WARNING on Serious Infections, Mortality, Malignancies, Major Adverse Cardiovascular Events, and Thrombosis. Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondyloarthritis Atopic Dermatitis Ulcerative Colitis Visit RINVOQhcp.com Plaque Psoriasis Psoriatic Arthritis Crohn’s Disease Visit SKYRIZIhcp.com Please see Important Safety Information, including BOXED WARNING on Serious Infections and Malignancy. Hidradenitis Suppurativa Juvenile Idiopathic Arthritis Pediatric Crohn’s Disease Pediatric Ulcerative Colitis Pediatric Uveitis Uveitis (Adult) Other Indications Visit HUMIRApro.com US-MULT-221082 Immunology Therapies Contact Medical Info Full Prescribing Information Patient Site Patient Support Resources & Forms Choose an Indication Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondyloarthritis Atopic Dermatitis Ulcerative Colitis Patient |
HTTP/1.0 301 Moved Permanently Location: http://www.rinvoqhcp.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Tue, 26 Oct 2021 00:59:31 GMT Content-Type: text/html Content-Length: 183 Connection: close Location: https://www.rinvoqhcp.com/ X-Cache: Redirect from cloudfront Via: 1.1 2c00b6f1d42245c6c3867cc4dfa7f32f.cloudfront.net (CloudFront) X-Amz-Cf-Pop: BOS50-C3 X-Amz-Cf-Id: nvMtvvyDJY8PXDl1Y5YugM4MwKRObujwv7ZQ6wQyJvX0DapHk1NvOg== HTTP/2 200 content-type: text/html;charset=utf-8 content-length: 453878 accept-ranges: bytes last-modified: Tue, 19 Oct 2021 22:53:14 GMT server: Apache strict-transport-security: max-age=31536000; includeSubDomains x-content-type-options: nosniff x-dispatcher: dispatcher1useast1 x-frame-options: SAMEORIGIN x-vhost: publish cache-control: max-age=300, public cache-control: no-cache="set-cookie" date: Tue, 26 Oct 2021 00:59:31 GMT etag: "6ecf6-5cebc86c84a80" x-cache: RefreshHit from cloudfront via: 1.1 6c6ab4e7ef4ce973c24e4eec4ec2c43d.cloudfront.net (CloudFront) x-amz-cf-pop: BOS50-C3 x-amz-cf-id: bWpmc7eR5SO1YKjR70CahnJ-WEgk2C4RlmpBWzN0-R0z3RnY5qhT-g== |
Domain Name: RINVOQHCP.COM Registry Domain ID: 2368572194_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-02-08T10:25:10Z Creation Date: 2019-03-12T15:59:30Z Registry Expiry Date: 2022-03-12T15:59:30Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ABVEGDMZNS1.ABBVIE.COM Name Server: ABVLUDMZNS1.ABBVIE.COM Name Server: ABVSGDMZNS1.ABBVIE.COM Name Server: NS-1450.AWSDNS-53.ORG Name Server: NS-1837.AWSDNS-37.CO.UK Name Server: NS-320.AWSDNS-40.COM Name Server: NS-620.AWSDNS-13.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T02:35:46Z <<< |